Form 8-K - Current report:
SEC Accession No. 0001558370-21-003397
Filing Date
2021-03-24
Accepted
2021-03-24 08:15:58
Documents
4
Period of Report
2021-03-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20210323x8k.htm 8-K 31956
2 EX-10.1 tmb-20210323xex10d1.htm EX-10.1 37953
3 EX-99.1 tmb-20210323xex99d1.htm EX-99.1 19580
4 GRAPHIC tmb-20210323xex99d1001.jpg GRAPHIC 8320
  Complete submission text file 0001558370-21-003397.txt   102371
Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37809 | Film No.: 21766724
SIC: 2834 Pharmaceutical Preparations